These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20488769)

  • 1. Amantadine for treatment of hepatitis C: time to say "enough is enough"?
    Piccolo P
    Dig Liver Dis; 2010 Jul; 42(7):468-9. PubMed ID: 20488769
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients.
    Langlet P; D'Heygere F; Henrion J; Adler M; Delwaide J; Van Vlierberghe H; Mulkay JP; Lasser L; Brenard R; Horsmans Y; Michielsen P; Laureys A; Nevens F
    Aliment Pharmacol Ther; 2009 Aug; 30(4):352-63. PubMed ID: 19485978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High dose repeat therapy in previously treated patients with chronic hepatitis C].
    Hoepffner N; Paul KA; Nikodem AB; Teuber G
    Dtsch Med Wochenschr; 2006 Mar; 131(11):543-4. PubMed ID: 16538557
    [No Abstract]   [Full Text] [Related]  

  • 4. No beneficial effects of amantadine in treatment of chronic hepatitis C patients.
    van Soest H; van der Schaar PJ; Koek GH; de Vries RA; van Ooteghem NA; van Hoek B; Drenth JP; Vrolijk JM; Lieverse RJ; Houben P; van der Sluys Veer A; Siersema PD; Schipper ME; van Erpecum KJ; Boland GJ
    Dig Liver Dis; 2010 Jul; 42(7):496-502. PubMed ID: 20018575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon alpha--hype or hope?
    Vogel W
    Wien Klin Wochenschr; 2004 Aug; 116(15-16):508-10. PubMed ID: 15471176
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction doses of interferon-alpha-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial.
    Salmerón J; Diago M; Andrade R; Pérez R; Solá R; Romero M; de la Mata M; Granados R; Ruiz-Extremera A; Muñoz de Rueda P
    J Viral Hepat; 2007 Feb; 14(2):89-95. PubMed ID: 17244248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.
    Dai CY; Huang CF; Chuang WL; Huang JF; Yu ML
    Am J Gastroenterol; 2009 Sep; 104(9):2358-9. PubMed ID: 19727098
    [No Abstract]   [Full Text] [Related]  

  • 8. Do differences in pegylation of interferon alfa matter?
    Zeuzem S
    Gastroenterology; 2010 Jan; 138(1):34-6. PubMed ID: 19932662
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
    Lo Nigro L; La Spina M; Mirabile E; Pisana P; Schilirò G; Guardo P
    Pediatr Blood Cancer; 2004 Aug; 43(2):185. PubMed ID: 15236293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic hepatitis C. First treatment].
    Colombato L; Descalzi V; Gadano A
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S37-9. PubMed ID: 20214297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C].
    Han KH; Yoon YH
    Korean J Hepatol; 2004 Jun; 10(2):81-7. PubMed ID: 15218341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.
    Zilly M; Lingenauber C; Desch S; Väth T; Klinker H; Langmann P
    Eur J Med Res; 2002 Apr; 7(4):149-54. PubMed ID: 12010649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential effects of interferon-based treatments in chronic hepatitis C].
    Nakamoto Y; Kaneko S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):485-7. PubMed ID: 15359846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of relapsers].
    Galdame O; Manero E; Reggiardo V
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S39-41. PubMed ID: 20214298
    [No Abstract]   [Full Text] [Related]  

  • 16. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Santin M; Shaw E
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812596
    [No Abstract]   [Full Text] [Related]  

  • 17. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Picon PD; Costa AF; Kuchenbecker R; Beltrame A
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812597
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress on the treatment of hepatitis C.
    Nierengarten MB
    Lancet Infect Dis; 2003 Dec; 3(12):748. PubMed ID: 14664249
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of cirrhosis: evidence-based medicine?
    Desmet VJ; Roskams T
    Gastroenterology; 2003 Aug; 125(2):629-30; author reply 630-31. PubMed ID: 12891578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.